Evidence map›Paper›PMID 33688357›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2020

Detrimental and Beneficial Effect of Autophagy and a Potential Therapeutic Target after Ischemic Stroke.

Meng Wang, Hangil Lee, Kenneth Elkin, Redina Bardhi, Longfei Guan, Ankush Chandra, Xiaokun Geng, Yuchuan Ding

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Mitophagy in Human Diseases.International journal of molecular sciences · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Meng WangChina-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Hangil LeeDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Kenneth ElkinDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Redina BardhiDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Longfei GuanChina-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Ankush ChandraDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Xiaokun GengChina-America Institute of Neuroscience, Beijing Luhe Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0001-8918-8748
Yuchuan DingDepartment of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA.
Wayne State University · USBeijing Luhe Hospital Affiliated to Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy, a physiologic mechanism that promotes energy recycling and orderly degradation through self-regulated disassembly of cellular components, helps maintain homeostasis. A series of evidences suggest that autophagy is activated as a response to ischemia and has been well-characterized as a therapeutic target. However, the role of autophagy after ischemia remains controversial. Activated-autophagy can remove necrotic substances against ischemic injury to promote cell survival. On the contrary, activation of autophagy may further aggravate ischemic injury, causing cell death. Therefore, the present review will examine the current understanding of the precise mechanism and role of autophagy in ischemia and recent neuroprotective therapies on autophagy, drug therapies, and nondrug therapies, including electroacupuncture (EA).

Identifiers

PMID33688357
PMCPMC7924073
OpenAlexW3087906464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.